{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:37:45Z","timestamp":1790725065570,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T00:00:00Z","timestamp":1409097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s40263-014-0197-8","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T04:59:08Z","timestamp":1409029148000},"page":"989-1003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Mood Stabilizers and Antipsychotics for Acute Mania: A Systematic Review and Meta-Analysis of Combination\/Augmentation Therapy Versus Monotherapy"],"prefix":"10.1007","volume":"28","author":[{"given":"Yusuke","family":"Ogawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aran","family":"Tajika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hayasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshi A.","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,27]]},"reference":[{"issue":"9859","key":"197_CR1","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163\u201396.","journal-title":"Lancet."},{"issue":"5","key":"197_CR2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","volume":"64","author":"KR Merikangas","year":"2007","unstructured":"Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64(5):543\u201352.","journal-title":"Arch Gen Psychiatry."},{"issue":"10","key":"197_CR3","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1176\/ps.50.10.1303","volume":"50","author":"GE Simon","year":"1999","unstructured":"Simon GE, Unutzer J. Health care utilization and costs among patients treated for bipolar disorder in an insured population. Psychiatr Serv. 1999;50(10):1303\u20138.","journal-title":"Psychiatr Serv."},{"issue":"2","key":"197_CR4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/15622970902823202","volume":"10","author":"H Grunze","year":"2009","unstructured":"Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry. 2009;10(2):85\u2013116.","journal-title":"World J Biol Psychiatry."},{"key":"197_CR5","unstructured":"NICE. Bipolar disorder. July 2006. http:\/\/publications.nice.org.uk\/bipolar-disorder-cg38 ."},{"issue":"4","key":"197_CR6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","volume":"23","author":"GM Goodwin","year":"2009","unstructured":"Goodwin GM, Psycho CGBA. Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2009;23(4):346\u201388.","journal-title":"J Psychopharmacol."},{"issue":"1","key":"197_CR7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0447.2006.00912.x","volume":"115","author":"LA Smith","year":"2007","unstructured":"Smith LA, Cornelius V, Warnock A, et al. Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy. Acta Psychiatr Scand. 2007;115(1):12\u201320.","journal-title":"Acta Psychiatr Scand."},{"issue":"4","key":"197_CR8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archpsyc.64.4.442","volume":"64","author":"H Scherk","year":"2007","unstructured":"Scherk H, Pajonk FG, Leucht S. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry. 2007;64(4):442\u201355.","journal-title":"Arch Gen Psychiatry."},{"issue":"2","key":"197_CR9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eurpsy.2004.12.002","volume":"20","author":"E Vieta","year":"2005","unstructured":"Vieta E. The treatment of mixed states and the risk of switching to depression. Eur Psychiatry. 2005;20(2):96\u2013100.","journal-title":"Eur Psychiatry."},{"key":"197_CR10","unstructured":"The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions. Updated March, 2011; 5.1.0 2011 http:\/\/handbook.cochrane.org\/ ."},{"issue":"Suppl. 439","key":"197_CR11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0447.2009.01383.x","volume":"119","author":"GS Malhi","year":"2009","unstructured":"Malhi GS, Adams D, Lampe L, et al. Clinical practice recommendations for bipolar disorder. Acta Psychiatr Scand. 2009;119(Suppl. 439):27\u201346.","journal-title":"Acta Psychiatr Scand."},{"issue":"3","key":"197_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials."},{"issue":"1","key":"197_CR13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004850-200501000-00010","volume":"20","author":"TA Furukawa","year":"2005","unstructured":"Furukawa TA, Cipriani A, Barbui C, et al. Imputing response rates from means and standard deviations in meta-analyses. Int Clin Psychopharmacol. 2005;20(1):49\u201352.","journal-title":"Int Clin Psychopharmacol."},{"issue":"7109","key":"197_CR14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ."},{"key":"197_CR15","unstructured":"Divalproex Extended Release and placebo, lithium, or quetiapine for mania. ClinicalTrials.gov. http:\/\/clinicaltrials.gov\/show\/NCT00183443 . Accessed 20 Sept 2013."},{"key":"197_CR16","unstructured":"Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder. ClinicalTrials.gov. http:\/\/clinicaltrials.gov\/show\/NCT01195363 . Accessed 20 Sept 2013."},{"issue":"1\u20133","key":"197_CR17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jad.2010.09.011","volume":"129","author":"J Berwaerts","year":"2011","unstructured":"Berwaerts J, Lane R, Nuamah IF, et al. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study. J Affect Disord. 2011;129(1\u20133):252\u201360.","journal-title":"J Affect Disord."},{"key":"197_CR18","unstructured":"Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder. ClinicalTrials.gov. http:\/\/clinicaltrials.gov\/show\/NCT00665366 . Accessed 20 Sep 2013."},{"issue":"4","key":"197_CR19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0165-0327(80)90029-4","volume":"2","author":"PE Garfinkel","year":"1980","unstructured":"Garfinkel PE, Stancer HC, Persad E. A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. J Affect Disord. 1980;2(4):279\u201388.","journal-title":"J Affect Disord."},{"issue":"11","key":"197_CR20","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4088\/JCP.08m04895yel","volume":"70","author":"JP Houston","year":"2009","unstructured":"Houston JP, Tohen M, Degenhardt EK, et al. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. J Clin Psychiatry. 2009;70(11):1540\u20137.","journal-title":"J Clin Psychiatry."},{"issue":"7","key":"197_CR21","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","volume":"159","author":"GS Sachs","year":"2002","unstructured":"Sachs GS, Grossman F, Ghaemi SN, et al. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry. 2002;159(7):1146\u201354.","journal-title":"Am J Psychiatry."},{"issue":"3","key":"197_CR22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-5618.2004.00115.x","volume":"6","author":"G Sachs","year":"2004","unstructured":"Sachs G, Chengappa KN, Suppes T, et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord. 2004;6(3):213\u201323.","journal-title":"Bipolar Disord."},{"issue":"11","key":"197_CR23","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.4088\/JCP.11m07388","volume":"73","author":"GS Sachs","year":"2012","unstructured":"Sachs GS, Vanderburg DG, Edman S, et al. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2012;73(11):1412\u20139.","journal-title":"J Clin Psychiatry."},{"issue":"1","key":"197_CR24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JCP.0b013e31823f872f","volume":"32","author":"A Szegedi","year":"2012","unstructured":"Szegedi A, Calabrese JR, Stet L, et al. Asenapine as adjunctive treatment for acute mania associated with bipolar disorder results of a 12-week core study and 40-week extension. J Clin Psychopharmacol. 2012;32(1):46\u201355.","journal-title":"J Clin Psychopharmacol."},{"issue":"1","key":"197_CR25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.59.1.62","volume":"59","author":"M Tohen","year":"2002","unstructured":"Tohen M, Chengappa KNR, Suppes T, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry. 2002;59(1):62\u20139.","journal-title":"Arch Gen Psychiatry."},{"issue":"2","key":"197_CR26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1192\/bjp.bp.107.041301","volume":"192","author":"M Tohen","year":"2008","unstructured":"Tohen M, Bowden CL, Smulevich AB, et al. Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes. Br J Psychiatry. 2008;192(2):135\u201343.","journal-title":"Br J Psychiatry."},{"issue":"10","key":"197_CR27","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1176\/appi.ajp.2008.07101560","volume":"165","author":"E Vieta","year":"2008","unstructured":"Vieta E, T\u2019joen C, McQuade RD, et al. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate\/lithium monotherapy: A placebo-controlled study. Am J Psychiatry. 2008;165(10):1316\u201325.","journal-title":"Am J Psychiatry."},{"issue":"SUPPL. 4","key":"197_CR28","doi-asserted-by":"crossref","first-page":"S344","DOI":"10.1016\/S0924-977X(03)92102-X","volume":"13","author":"RH Weisler","year":"2003","unstructured":"Weisler RH, Dunn J, English P. Ziprasidone in adjunctive treatment of acute mania: a randomised, double-blind, placebo-controlled trial. Eur Neuropsychopharmacol. 2003;13(SUPPL. 4):S344\u20135.","journal-title":"Eur Neuropsychopharmacol."},{"key":"197_CR29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1192\/bjp.182.2.141","volume":"182","author":"LN Yatham","year":"2003","unstructured":"Yatham LN, Grossman F, Augustyns I, et al. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br J Psychiatry. 2003;182:369.","journal-title":"Br J Psychiatry."},{"issue":"4","key":"197_CR30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/YIC.0b013e328080ca57","volume":"22","author":"LN Yatham","year":"2007","unstructured":"Yatham LN, Vieta E, Young AH, et al. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania. Int Clin Psychopharmacol. 2007;22(4):212\u201320.","journal-title":"Int Clin Psychopharmacol."},{"issue":"3","key":"197_CR31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.1979.01780030093009","volume":"36","author":"J Biederman","year":"1979","unstructured":"Biederman J, Lerner Y, Belmaker RH. Combination of lithium carbonate and haloperidol in schizo-affective disorder: a controlled study. Arch Gen Psychiatry. 1979;36(3):327\u201333.","journal-title":"Arch Gen Psychiatry."},{"key":"197_CR32","unstructured":"Bourin M. An international, multicenter, double-blind, randomized, placebo-controlled, phase IV study of the safety and efficacy of lithium versus placebo as an add on to SEROQUEL XR (Quetiapine Fumarate) in adult patients with acute mania. AstraZeneca Clinical Trials. http:\/\/www.astrazenecaclinicaltrials.com\/_mshost800325\/content\/clinical-trials\/resources\/pdf\/D144AC00003 . Accessed 20 Sept 2013."},{"issue":"6","key":"197_CR33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00004714-199912000-00003","volume":"19","author":"JC Chou","year":"1999","unstructured":"Chou JC, Czobor P, Charles O, et al. Acute mania: haloperidol dose and augmentation with lithium or lorazepam. J Clin Psychopharmacol. 1999;19(6):500\u20135.","journal-title":"J Clin Psychopharmacol."},{"issue":"1\u20132","key":"197_CR34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0278-5846(89)90009-2","volume":"13","author":"HJ M\u00f6ller","year":"1989","unstructured":"M\u00f6ller HJ, Kissling W, Riehl T, et al. Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(1\u20132):127\u201336.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"issue":"2","key":"197_CR35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00004714-200004000-00012","volume":"20","author":"B M\u00fcller-Oerlinghausen","year":"2000","unstructured":"M\u00fcller-Oerlinghausen B, Retzow A, Henn FA, et al. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group. J Clin Psychopharmacol. 2000;20(2):195\u2013203.","journal-title":"J Clin Psychopharmacol."},{"issue":"1\u20133","key":"197_CR36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2008.05.014","volume":"112","author":"PE Keck","year":"2009","unstructured":"Keck PE, Orsulak PJ, Cutler AJ, et al. Aripiprazole monotherapy in the treatment of acute bipolar I mania: A randomized, double-blind, placebo- and lithium-controlled study. J Affect Disord. 2009;112(1\u20133):36\u201349.","journal-title":"J Affect Disord."},{"issue":"1\u20133","key":"197_CR37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jad.2007.04.020","volume":"105","author":"G Niufan","year":"2008","unstructured":"Niufan G, Tohen M, Qiuqing A, et al. Olanzapine versus lithium in the acute treatment of bipolar mania: A double-blind, randomized, controlled trial. J Affect Disord. 2008;105(1\u20133):101\u20138.","journal-title":"J Affect Disord."},{"issue":"6","key":"197_CR38","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1176\/appi.ajp.159.6.1011","volume":"159","author":"M Tohen","year":"2002","unstructured":"Tohen M, Baker RW, Altshuler LL, et al. Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry. 2002;159(6):1011\u20137.","journal-title":"Am J Psychiatry."},{"issue":"11","key":"197_CR39","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4088\/JCP.v69n1113","volume":"69","author":"M Tohen","year":"2008","unstructured":"Tohen M, Vieta E, Goodwin GM, et al. Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. J Clin Psychiatry. 2008;69(11):1776\u201389.","journal-title":"J Clin Psychiatry."},{"issue":"9799","key":"197_CR40","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","volume":"378","author":"A Cipriani","year":"2011","unstructured":"Cipriani A, Barbui C, Salanti G, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. 2011;378(9799):1306\u201315.","journal-title":"Lancet."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-014-0197-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-014-0197-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-014-0197-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:41:22Z","timestamp":1559490082000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-014-0197-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,27]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["197"],"URL":"https:\/\/doi.org\/10.1007\/s40263-014-0197-8","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,27]]}}}